Clinical Trial

Impact of Mindful Self-Compassion Therapy on Self Harm Behaviors, Emotional Regulation and Quality of Life Among Patients With Borderline Personality Disorder

Completed
View on ClinicalTrials.gov →
Summary
The primary purpose of the study is to investigate whether Mindful Self-Compassion (MSC) therapy can significantly reduce self-harm behaviors, improve emotional regulation, and enhance the quality of life in individuals diagnosed with Borderline Personality Disorder (BPD). The study aims to contribute to the existing literature by providing robust evidence on the efficacy of MSC therapy for BPD, which could inform clinical practices and improve treatment outcomes
Protocol Amendment History 2 changes
critical Trial completed 2026-08-11
notable Enrollment increased: 60 -> 70 participants 2026-08-11
Trial Details
NCT Number NCT06699732
Lead Sponsor Fatima Jinnah Women University
Conditions Psychological Distress, Emotional Regulation, Self Harm, Quality of Life (QOL), Borderline Personality Disorder (BPD)
Enrollment 70 participants
Start Date 2024-09-21
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-10